Effect of exacerbations on lung density in alpha-1 antitrypsin deficiency: Subgroup analysis of the RAPID trial programme

C. Strange (Charleston, United States of America), N. McElvaney (Dublin, Ireland), C. Vogelmeier (Marburg, Germany), M. Fries (King of Prussia, United States of America), J. Shah (King of Prussia, United States of America), A. Shebl (Marburg, Germany), O. Vit (Bern, Switzerland), M. Wencker (Loerzweiler, Germany), K. Chapman (Toronto, Canada)

Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Session: COPD phenotypes: a1 antitrypsin deficiency and beyond
Session type: Poster Discussion
Number: 568
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Strange (Charleston, United States of America), N. McElvaney (Dublin, Ireland), C. Vogelmeier (Marburg, Germany), M. Fries (King of Prussia, United States of America), J. Shah (King of Prussia, United States of America), A. Shebl (Marburg, Germany), O. Vit (Bern, Switzerland), M. Wencker (Loerzweiler, Germany), K. Chapman (Toronto, Canada). Effect of exacerbations on lung density in alpha-1 antitrypsin deficiency: Subgroup analysis of the RAPID trial programme. 568

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: